Brief: Bioretec Expects European Marketing Authorization For Remeos Trauma Screw To Be Delayed From Original Estimate Of 2022

Bioretec Oy

04/11/2022 16:19

Nov 4 (Reuters) - Bioretec Oy  BRETEC.HE :
    * BIORETEC UPDATES ITS ESTIMATE OF THE TIMING FOR APPROVAL
OF THE
CE MARK FOR THE REMEOS™ TRAUMA SCREW
    * EXPECTS EUROPEAN MARKETING AUTHORIZATION FOR REMEOS™
TRAUMA
SCREW TO BE DELAYED FROM ORIGINAL ESTIMATE OF 2022
    * ESTIMATES OBTAINING A MARKET AUTHORIZATION WILL MOVE TO
2023

Source text for Eikon:  ID:nWkr8VvSl7 
Further company coverage:  BRETEC.HE 
 ((Reuters.Briefs@thomsonreuters.com;))